Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão

MLA

Viroj Wiwanitkit, and Beuy Joob. “Response to: ‘Patients with Lupus Are Not Protected from COVID-19: A Comment’ by Sawalha, ‘No Evidence so Far on the Protective Effect of Hydroxycloroquin to Prevent COVID-19: Response to the Comment by Joob and Wiwanitkit’ by Romão.” Annals of the Rheumatic Diseases, vol. 80, no. 2, Apr. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....821d8b5e51cf31d325867474126f2674&authtype=sso&custid=ns315887.

APA

Viroj Wiwanitkit, & Beuy Joob. (2020). Response to: “Patients with lupus are not protected from COVID-19: a comment” by Sawalha, “No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit” by Romão. Annals of the Rheumatic Diseases, 80(2).

Chicago

Viroj Wiwanitkit, and Beuy Joob. 2020. “Response to: ‘Patients with Lupus Are Not Protected from COVID-19: A Comment’ by Sawalha, ‘No Evidence so Far on the Protective Effect of Hydroxycloroquin to Prevent COVID-19: Response to the Comment by Joob and Wiwanitkit’ by Romão.” Annals of the Rheumatic Diseases 80 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....821d8b5e51cf31d325867474126f2674&authtype=sso&custid=ns315887.